ValuEngine upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a strong sell rating to a sell rating in a report published on Friday, ValuEngine reports.

Other equities research analysts have also issued research reports about the stock. TheStreet lowered shares of TESSCO Technologies from a b- rating to a c rating in a report on Tuesday, July 23rd. Zacks Investment Research lowered shares of Hanger from a hold rating to a sell rating in a report on Tuesday, May 28th. Finally, CIBC reiterated a hold rating and set a $84.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday, May 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $57.77.

PBH stock opened at $34.05 on Friday. Prestige Consumer Healthcare has a 12 month low of $26.25 and a 12 month high of $41.76. The company has a debt-to-equity ratio of 1.64, a quick ratio of 1.43 and a current ratio of 2.37. The business’s 50-day moving average price is $31.56. The stock has a market cap of $1.72 billion, a PE ratio of 12.25, a PEG ratio of 1.91 and a beta of 0.93.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.02. Prestige Consumer Healthcare had a negative net margin of 3.67% and a positive return on equity of 12.45%. The firm had revenue of $241.03 million during the quarter, compared to analysts’ expectations of $237.22 million. During the same period in the previous year, the company earned $0.62 EPS. The firm’s revenue for the quarter was down 5.8% compared to the same quarter last year. On average, equities research analysts predict that Prestige Consumer Healthcare will post 2.81 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in PBH. Thrivent Financial for Lutherans raised its holdings in shares of Prestige Consumer Healthcare by 2.7% in the 4th quarter. Thrivent Financial for Lutherans now owns 13,137 shares of the company’s stock valued at $406,000 after purchasing an additional 347 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Prestige Consumer Healthcare by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 37,594 shares of the company’s stock valued at $1,191,000 after purchasing an additional 400 shares in the last quarter. Mason Street Advisors LLC raised its holdings in shares of Prestige Consumer Healthcare by 1.6% in the 1st quarter. Mason Street Advisors LLC now owns 27,545 shares of the company’s stock valued at $824,000 after purchasing an additional 445 shares in the last quarter. Diversified Trust Co raised its holdings in shares of Prestige Consumer Healthcare by 8.2% in the 2nd quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock valued at $272,000 after purchasing an additional 650 shares in the last quarter. Finally, Legal & General Group Plc raised its holdings in shares of Prestige Consumer Healthcare by 2.4% in the 4th quarter. Legal & General Group Plc now owns 52,367 shares of the company’s stock valued at $1,618,000 after purchasing an additional 1,251 shares in the last quarter.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: Certificate of Deposit (CD)

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.